Published in Kidney Int on February 02, 2011
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med (2013) 7.98
Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet (2012) 4.75
Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis (2013) 3.82
Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA (2014) 3.53
Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease. Kidney Int (2013) 2.48
Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ (2013) 2.24
Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). J Am Coll Cardiol (2012) 2.22
Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis (2014) 2.16
Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. J Am Coll Cardiol (2013) 1.89
Pro: 'The usefulness of biomarkers in glomerular diseases'. The problem: moving from syndrome to mechanism--individual patient variability in disease presentation, course and response to therapy. Nephrol Dial Transplant (2015) 1.73
The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int (2012) 1.68
Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet (2012) 1.68
Acute dialysis risk in living kidney donors. Nephrol Dial Transplant (2012) 1.60
Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts. Circulation (2012) 1.59
Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates. Am J Kidney Dis (2013) 1.54
Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK). Am J Kidney Dis (2014) 1.52
Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011) (2013) 1.51
A prospective controlled study of living kidney donors: three-year follow-up. Am J Kidney Dis (2015) 1.48
A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury. Am J Kidney Dis (2015) 1.46
Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial. Nephrol Dial Transplant (2015) 1.42
Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA (2015) 1.38
A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury. Am J Kidney Dis (2015) 1.30
Identification of incident CKD stage 3 in research studies. Am J Kidney Dis (2014) 1.29
Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death. Clin J Am Soc Nephrol (2011) 1.20
Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA (2016) 1.19
Low income and albuminuria among REGARDS (Reasons for Geographic and Racial Differences in Stroke) study participants. Am J Kidney Dis (2012) 1.09
Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study. J Acquir Immune Defic Syndr (2016) 1.08
Endocytosis of albumin by podocytes elicits an inflammatory response and induces apoptotic cell death. PLoS One (2013) 1.07
Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging. BMC Res Notes (2014) 1.06
KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methods. BMC Nephrol (2014) 1.04
Considerations in the optimal preparation of patients for dialysis. Nat Rev Nephrol (2012) 1.03
Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes. Clin J Am Soc Nephrol (2012) 1.03
Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View. Clin J Am Soc Nephrol (2015) 1.03
Estimated GFR, albuminuria, and complications of chronic kidney disease. J Am Soc Nephrol (2011) 1.01
Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP). Am J Kidney Dis (2014) 0.99
Early chronic kidney disease: diagnosis, management and models of care. Nat Rev Nephrol (2015) 0.98
Living donor practices in the United States. Adv Chronic Kidney Dis (2012) 0.96
The unjustified classification of kidney donors as patients with CKD: critique and recommendations. Clin J Am Soc Nephrol (2013) 0.95
Racial differences in albuminuria, kidney function, and risk of stroke. Neurology (2012) 0.94
Chronic kidney disease defined by cystatin C predicts mobility disability and changes in gait speed: the Framingham Offspring Study. J Gerontol A Biol Sci Med Sci (2013) 0.93
Nurse practitioner care improves renal outcome in patients with CKD. J Am Soc Nephrol (2013) 0.92
Assessing risk in chronic kidney disease: a methodological review. Nat Rev Nephrol (2012) 0.91
Tubular Secretion in CKD. J Am Soc Nephrol (2015) 0.91
The impact of different GFR estimating equations on the prevalence of CKD and risk groups in a Southeast Asian cohort using the new KDIGO guidelines. BMC Nephrol (2012) 0.90
End-stage renal disease and low level exposure to lead, cadmium and mercury; a population-based, prospective nested case-referent study in Sweden. Environ Health (2013) 0.89
Validation study of medicare claims to identify older US adults with CKD using the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis (2014) 0.89
Association of estimated glomerular filtration rate and urinary uromodulin concentrations with rare variants identified by UMOD gene region sequencing. PLoS One (2012) 0.89
The impacts of albuminuria and low eGFR on the risk of cardiovascular death, all-cause mortality, and renal events in diabetic patients: meta-analysis. PLoS One (2013) 0.88
Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar. Kidney Int (2014) 0.88
The glomerular filtration rate estimated by new and old equations as a predictor of important outcomes in elderly patients. BMC Med (2014) 0.88
Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2016) 0.88
Derivation and validation of a renal risk score for people with type 2 diabetes. Diabetes Care (2013) 0.87
The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol. BMC Nephrol (2013) 0.87
Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study. Clin J Am Soc Nephrol (2015) 0.87
Inflammation and Progression of CKD: The CRIC Study. Clin J Am Soc Nephrol (2016) 0.87
The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrol (2015) 0.87
Using mathematical algorithms to modify glomerular filtration rate estimation equations. PLoS One (2013) 0.86
Screening for chronic kidney disease: preventing harm or harming the healthy? PLoS Med (2012) 0.86
Past Decline Versus Current eGFR and Subsequent ESRD Risk. J Am Soc Nephrol (2015) 0.86
The Prevalence of Renal Failure. Dtsch Arztebl Int (2016) 0.86
Development and validation of an electronic phenotyping algorithm for chronic kidney disease. AMIA Annu Symp Proc (2014) 0.85
Association between First Nations ethnicity and progression to kidney failure by presence and severity of albuminuria. CMAJ (2013) 0.85
Glomerular and tubular damage markers in individuals with progressive albuminuria. Clin J Am Soc Nephrol (2013) 0.85
Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes. Diabetes (2015) 0.85
Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population. Korean J Intern Med (2016) 0.84
Electronic problem list documentation of chronic kidney disease and quality of care. BMC Nephrol (2014) 0.84
Risk factors for acute kidney injury after hip fracture surgery in the elderly individuals. Geriatr Orthop Surg Rehabil (2012) 0.84
Association of inflammatory and endothelial cell activation biomarkers with acute kidney injury after sepsis. Springerplus (2014) 0.84
Comparison of associations of urine protein-creatinine ratio versus albumin-creatinine ratio with complications of CKD: a cross-sectional analysis. Am J Kidney Dis (2013) 0.84
Coronary Artery Bypass Grafting Surgery Off- or On-pump Revascularisation Study (CORONARY): kidney substudy analytic protocol of an international randomised controlled trial. BMJ Open (2012) 0.84
Timeliness in chronic kidney disease and albuminuria identification: a retrospective cohort study. BMC Fam Pract (2015) 0.84
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP). Am J Kidney Dis (2016) 0.83
Disease progression subtype discovery from longitudinal EMR data with a majority of missing values and unknown initial time points. AMIA Annu Symp Proc (2014) 0.83
The Role of Acute Kidney Injury in Chronic Kidney Disease. Semin Nephrol (2016) 0.82
Urinary MicroRNA Profiling Predicts the Development of Microalbuminuria in Patients with Type 1 Diabetes. J Clin Med (2015) 0.82
Prevalence of Chronic Kidney Disease in Korea: the Korean National Health and Nutritional Examination Survey 2011-2013. J Korean Med Sci (2016) 0.82
Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J Nephrol (2015) 0.82
GPs' views on managing advanced chronic kidney disease in primary care: a qualitative study. Br J Gen Pract (2015) 0.82
Risk Prediction for Early CKD in Type 2 Diabetes. Clin J Am Soc Nephrol (2015) 0.82
The impact of chronic kidney disease and cardiovascular comorbidity on mortality in a multiethnic population: a retrospective cohort study. BMJ Open (2013) 0.81
Fibroblast growth factor-23 and the long-term risk of hospital-associated AKI among community-dwelling older individuals. Clin J Am Soc Nephrol (2013) 0.81
Optimising the accuracy of blood pressure monitoring in chronic kidney disease: the utility of BpTRU. BMC Nephrol (2013) 0.81
Association of albumin-creatinine ratio and cystatin C with change in ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis (2014) 0.81
Predicting 5-Year Risk of RRT in Stage 3 or 4 CKD: Development and External Validation. Clin J Am Soc Nephrol (2016) 0.80
A quality improvement project to improve the effectiveness and patient-centredness of management of people with mild-to-moderate kidney disease in primary care. BMJ Qual Improv Rep (2014) 0.80
Five-year incidence of chronic kidney disease (stage 3-5) and associated risk factors in a Spanish cohort: the MADIABETES Study. PLoS One (2015) 0.80
Tribbles homolog 3 attenuates mammalian target of rapamycin complex-2 signaling and inflammation in the diabetic kidney. J Am Soc Nephrol (2014) 0.80
Added value of screening for CKD among the elderly or persons with low socioeconomic status. Clin J Am Soc Nephrol (2015) 0.80
Improvement in kidney function: a real occurrence. J Am Soc Nephrol (2012) 0.79
Lifetime Risk of Stage 3-5 CKD in a Community-Based Sample in Iceland. Clin J Am Soc Nephrol (2015) 0.79
Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis. Clin J Am Soc Nephrol (2016) 0.79
Relationship of Albuminuria and Renal Artery Stent Outcomes: Results From the CORAL Randomized Clinical Trial (Cardiovascular Outcomes With Renal Artery Lesions). Hypertension (2016) 0.78
Smoking increases the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease. Kidney Int (2015) 0.78
Chronic kidney disease: Albuminuria or CKD stage as best marker of CVD in diabetes? Nat Rev Nephrol (2012) 0.78
Novel drugs and intervention strategies for the treatment of chronic kidney disease. Br J Clin Pharmacol (2013) 0.78
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet (2008) 13.34
Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2005) 10.42
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int (2010) 9.25
Relation between kidney function, proteinuria, and adverse outcomes. JAMA (2010) 8.26
Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int (2007) 7.75
An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant (2008) 7.23
All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet (2008) 7.09
Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med (2003) 5.47
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
Age affects outcomes in chronic kidney disease. J Am Soc Nephrol (2007) 5.36
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25
Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med (2007) 4.58
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol (2009) 4.43
Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol (2009) 4.31
Proteinuria and the risk of developing end-stage renal disease. Kidney Int (2003) 3.73
Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol (2006) 3.51
Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol (2008) 3.44
Early identification and management of chronic kidney disease: summary of NICE guidance. BMJ (2008) 3.24
The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol (2006) 2.89
Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol (2006) 2.78
Dissecting and refining the staging of chronic kidney disease. Kidney Int (2009) 2.72
Definition and classification of CKD: the debate should be about patient prognosis--a position statement from KDOQI and KDIGO. Am J Kidney Dis (2009) 2.61
Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol (2009) 2.43
Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study. Clin J Am Soc Nephrol (2006) 2.37
A simple algorithm to predict incident kidney disease. Arch Intern Med (2008) 2.36
Screening for albuminuria identifies individuals at increased renal risk. J Am Soc Nephrol (2009) 2.24
Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. Am J Nephrol (2009) 2.10
Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). Kidney Int (1998) 1.99
Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion. Nephrol Dial Transplant (2008) 1.89
Effect of telmisartan on renal outcomes: a randomized trial. Ann Intern Med (2009) 1.85
Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res (2008) 1.70
The case for using albuminuria in staging chronic kidney disease. J Am Soc Nephrol (2009) 1.67
Long-term outcomes of acute kidney injury. Adv Chronic Kidney Dis (2008) 1.40
Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes. Am J Kidney Dis (2008) 1.39
Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am J Kidney Dis (2004) 1.38
The role of specialists in managing the health of populations with chronic illness: the example of chronic kidney disease. BMJ (2009) 1.36
Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis (2008) 1.34
Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin Exp Nephrol (2007) 1.33
Long-term outcomes of acute kidney injury. Curr Opin Nephrol Hypertens (2010) 1.07
CKD classification: time to move beyond KDOQI. J Am Soc Nephrol (2009) 1.01
Age- and gender-specific reference values of estimated glomerular filtration rate in a Caucasian population: Results of the Nijmegen Biomedical Study. Kidney Int (2008) 0.98
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33
Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis (2003) 15.00
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med (2010) 13.25
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med (2013) 11.10
Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52
Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2005) 10.42
MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int (2010) 9.25
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol (2006) 8.61
Severe hypoglycemia and risks of vascular events and death. N Engl J Med (2010) 8.54
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol (2004) 8.21
Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med (2013) 7.98
Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis (2007) 7.86
International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol (2006) 7.51
Common variants in the GDF5-UQCC region are associated with variation in human height. Nat Genet (2008) 7.31
Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation (2002) 7.25
Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20
Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03
Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ (2005) 6.83
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int (2004) 6.32
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet (2014) 6.23
Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00
Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90
Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet (2008) 5.89
Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? J Urol (2008) 5.70
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med (2010) 5.48
Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med (2003) 5.47
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45
Chronic kidney disease. Lancet (2011) 5.42
Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet (2011) 5.33
The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med (2002) 5.33